F666-0751 Screening compound: 1-(3-ethyl-6-methyl-2,4-dioxo-1-phenyl-1,2,3,4-tetrahydropyrimidin-5-yl)-N-[3-(morpholin-4-yl)propyl]piperidine-4-carboxamide

F666-0751 Screening compound: 1-(3-ethyl-6-methyl-2,4-dioxo-1-phenyl-1,2,3,4-tetrahydropyrimidin-5-yl)-N-[3-(morpholin-4-yl)propyl]piperidine-4-carboxamide
F666-0751 Screening compound: 1-(3-ethyl-6-methyl-2,4-dioxo-1-phenyl-1,2,3,4-tetrahydropyrimidin-5-yl)-N-[3-(morpholin-4-yl)propyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F666-0751
1-(3-ethyl-6-methyl-2,4-dioxo-1-phenyl-1,2,3,4-tetrahydropyrimidin-5-yl)-N-[3-(morpholin-4-yl)propyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F666-0751

Molecular Formula

C26H37N5O4 (C26 H37 N5 O4)

Compound Name

1-(3-ethyl-6-methyl-2,4-dioxo-1-phenyl-1,2,3,4-tetrahydropyrimidin-5-yl)-N-[3-(morpholin-4-yl)propyl]piperidine-4-carboxamide

IUPAC name

1-(3-ethyl-6-methyl-24-dioxo-1-phenyl-1234-tetrahydropyrimidin-5-yl)-N-[3-(morpholin-4-yl)propyl]piperidine-4-carboxamide

SMILES

CCN(C(C(N(CC1)CCC1C(NCCCN1CCOCC1)=O)=C(C)N1c2ccccc2)=O)C1=O

InChI

InChI=1S/C26H37N5O4/c1-3-30-25(33)23(20(2)31(26(30)34)22-8-5-4-6-9-22)29-14-10-21(11-15-29)24(32)27-12-7-13-28-16-18-35-19-17-28/h4-6,8-9,21H,3,7,10-19H2,1-2H3,(H,27,32)

InChI Key

JSSOOFRVUNHWMV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14961612

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.139

Distribution Coefficient, logD

0.551

Water Solubility, LogSw

-1.85

Polar Surface Area

70.669

Acid Dissociation Constant (pKa)

15.07

Base Dissociation Constant (pKb)

2.93

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.70

F666-0751 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

MCL1 Targeted Library (12200 compounds)

Nucleoside Mimetics Library (2197 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Cancer
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with F666-0751 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F666-0751?
Check Price and Availability of F666-0751, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F666-0751 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F666-0751
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F666-0751
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F666-0751 available by request